Ppd Development, Lp
Clinical trials sponsored by Ppd Development, Lp, explained in plain language.
-
New hope for ARDS: experimental drug aims to boost survival in severe lung failure
Disease control Recruiting nowThis study tests an experimental drug called paridiprubart in adults hospitalized with moderate-to-severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. About 200 participants will receive either the drug or a placebo to see if it improves survival…
Phase: PHASE2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated May 26, 2026 06:04 UTC
-
New hope for ARDS: bevacizumab trial aims to improve survival
Disease control Recruiting nowThis study tests whether a drug called bevacizumab can help adults hospitalized with acute respiratory distress syndrome (ARDS), a severe lung condition. About 200 participants will receive either the drug or a placebo, and researchers will track survival rates and oxygen levels.…
Phase: PHASE2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
New hope for ARDS: major trial tests multiple therapies in 600 patients
Disease control Recruiting nowThis study tests several experimental treatments for adults hospitalized with acute respiratory distress syndrome (ARDS), a severe lung condition. About 600 participants will receive either an active drug or a placebo to see if the treatments improve survival and are safe. The ma…
Phase: PHASE2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
New drug trial aims to boost survival in severe lung failure patients
Disease control Recruiting nowThis study tests a drug called vilobelimab in adults hospitalized with severe lung failure (ARDS). About 200 participants will receive either the drug or a placebo. The main goal is to see if the drug reduces deaths within 28 days.
Phase: PHASE2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated May 14, 2026 12:02 UTC